SIERRA ONCOLOGY, INC. Research and Development Expense
SIERRA ONCOLOGY, INC. reported Research and Development Expense of $17.55 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2022-05-06
- SIERRA ONCOLOGY, INC. research and development expense for the quarter ending 2022-03-31 was $17.55M, a 25.81% increase year-over-year.
- SIERRA ONCOLOGY, INC. research and development expense for the quarter ending 2021-12-31 was $17.43M, a 35.05% increase year-over-year.
- SIERRA ONCOLOGY, INC. research and development expense for the quarter ending 2021-09-30 was $21.62M, a 107.23% increase year-over-year.
- SIERRA ONCOLOGY, INC. research and development expense for the quarter ending 2021-06-30 was $14.15M, a 38.87% increase year-over-year.
- SIERRA ONCOLOGY, INC. research and development expense for fiscal 2021 was $67.15M, a 48.83% increase from fiscal 2020.
- SIERRA ONCOLOGY, INC. research and development expense for fiscal 2020 was $45.12M, a 15.27% decline from fiscal 2019.
- SIERRA ONCOLOGY, INC. research and development expense for fiscal 2019 was $53.25M, a 29.63% increase from fiscal 2018.
- SIERRA ONCOLOGY, INC. research and development expense for fiscal 2018 was $41.08M, a 36.21% increase from fiscal 2017.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2022-03-31 | $17.55M 10-Q · filed 2022-05-06 | $34.98M derived: sum of 2 quarters · filed 2022-05-06 | $56.60M derived: sum of 3 quarters · filed 2022-05-06 | $70.75M derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-12-31 | $17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $39.05M derived: sum of 2 quarters · filed 2022-03-10 | $53.20M derived: sum of 3 quarters · filed 2022-03-10 | $67.15M 10-K · filed 2022-03-10 |
| 2021-09-30 | $21.62M 10-Q · filed 2021-11-05 | $35.77M derived: sum of 2 quarters · filed 2021-11-05 | $49.72M 10-Q · filed 2021-11-05 | $62.63M derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-06-30 | $14.15M 10-Q · filed 2021-08-05 | $28.10M 10-Q · filed 2021-08-05 | $41.01M derived: sum of 3 quarters · filed 2022-05-06 | $51.44M derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-03-31 | $13.95M 10-Q · filed 2022-05-06 | $26.86M derived: sum of 2 quarters · filed 2022-05-06 | $37.29M derived: sum of 3 quarters · filed 2022-05-06 | $47.48M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $12.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $23.34M derived: sum of 2 quarters · filed 2022-03-10 | $33.53M derived: sum of 3 quarters · filed 2022-03-10 | $45.12M 10-K · filed 2022-03-10 |
| 2020-09-30 | $10.43M 10-Q · filed 2021-11-05 | $20.62M derived: sum of 2 quarters · filed 2021-11-05 | $32.21M 10-Q · filed 2021-11-05 | $53.48M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $10.19M 10-Q · filed 2021-08-05 | $21.78M 10-Q · filed 2021-08-05 | $43.05M derived: sum of 3 quarters · filed 2022-03-10 | $53.16M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $11.59M 10-Q · filed 2021-05-07 | $32.86M derived: sum of 2 quarters · filed 2022-03-10 | $42.98M derived: sum of 3 quarters · filed 2022-03-10 | $54.70M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $21.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $31.38M derived: sum of 2 quarters · filed 2022-03-10 | $43.11M derived: sum of 3 quarters · filed 2022-03-10 | $53.25M 10-K · filed 2022-03-10 |
| 2019-09-30 | $10.11M 10-Q · filed 2020-11-05 | $21.84M derived: sum of 2 quarters · filed 2020-11-05 | $31.98M 10-Q · filed 2020-11-05 | $43.02M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $11.73M 10-Q · filed 2020-08-06 | $21.86M 10-Q · filed 2020-08-06 | $32.91M derived: sum of 3 quarters · filed 2021-03-11 | $45.82M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $10.14M 10-Q · filed 2020-05-07 | $21.18M derived: sum of 2 quarters · filed 2021-03-11 | $34.10M derived: sum of 3 quarters · filed 2021-03-11 | $42.88M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $11.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $23.96M derived: sum of 2 quarters · filed 2021-03-11 | $32.74M derived: sum of 3 quarters · filed 2021-03-11 | $41.08M 10-K · filed 2021-03-11 |
| 2018-09-30 | $12.91M 10-Q · filed 2019-11-04 | $21.70M derived: sum of 2 quarters · filed 2019-11-04 | $30.03M 10-Q · filed 2019-11-04 | $37.58M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | $8.79M 10-Q · filed 2019-08-08 | $17.12M 10-Q · filed 2019-08-08 | $24.67M derived: sum of 3 quarters · filed 2020-03-03 | $32.07M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | $8.33M 10-Q · filed 2019-05-08 | $15.88M derived: sum of 2 quarters · filed 2020-03-03 | $23.29M derived: sum of 3 quarters · filed 2020-03-03 | $30.48M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | $7.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $14.96M derived: sum of 2 quarters · filed 2020-03-03 | $22.15M derived: sum of 3 quarters · filed 2020-03-03 | $30.16M 10-K · filed 2020-03-03 |
| 2017-09-30 | $7.41M 10-Q · filed 2018-11-08 | $14.60M derived: sum of 2 quarters · filed 2018-11-08 | $22.61M 10-Q · filed 2018-11-08 | $28.43M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $7.19M 10-Q · filed 2018-08-09 | $15.20M 10-Q · filed 2018-08-09 | $21.02M derived: sum of 3 quarters · filed 2019-02-28 | $33.35M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $8.01M 10-Q · filed 2018-05-10 | $13.83M derived: sum of 2 quarters · filed 2019-02-28 | $26.15M derived: sum of 3 quarters · filed 2019-02-28 | $35.27M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $18.14M derived: sum of 2 quarters · filed 2019-02-28 | $27.26M derived: sum of 3 quarters · filed 2019-02-28 | $33.90M 10-K · filed 2019-02-28 |
| 2016-09-30 | $12.32M 10-Q · filed 2017-11-08 | $21.44M derived: sum of 2 quarters · filed 2017-11-08 | $28.07M 10-Q · filed 2017-11-08 | $36.10M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $9.12M 10-Q · filed 2017-08-10 | $15.75M 10-Q · filed 2017-08-10 | $23.78M derived: sum of 3 quarters · filed 2018-02-27 | $32.07M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $6.64M 10-Q · filed 2017-05-09 | $14.66M derived: sum of 2 quarters · filed 2018-02-27 | $22.96M derived: sum of 3 quarters · filed 2018-02-27 | $27.70M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $16.32M derived: sum of 2 quarters · filed 2018-02-27 | $21.06M derived: sum of 3 quarters · filed 2018-02-27 | $26.36M 10-K · filed 2018-02-27 |
| 2015-09-30 | $8.29M 10-Q · filed 2016-11-10 | $13.03M derived: sum of 2 quarters · filed 2016-11-10 | $18.33M 10-Q · filed 2016-11-10 | $20.43M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $4.74M 10-Q · filed 2016-08-12 | $10.03M 10-Q · filed 2016-08-12 | $12.13M derived: sum of 3 quarters · filed 2017-03-02 | $14.57M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-03-31 | $5.30M 10-Q · filed 2016-05-10 | $7.39M derived: sum of 2 quarters · filed 2017-03-02 | $9.83M derived: sum of 3 quarters · filed 2017-03-02 | $22.55M derived: sum of 4 quarters · filed 2017-03-02 |
| 2014-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $4.53M derived: sum of 2 quarters · filed 2017-03-02 | $17.25M derived: sum of 3 quarters · filed 2017-03-02 | $19.08M 10-K · filed 2017-03-02 |
| 2014-09-30 | $2.44M 10-Q · filed 2015-11-05 | $15.15M derived: sum of 2 quarters · filed 2015-11-05 | $16.98M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $12.72M 10-Q · filed 2015-08-21 | $14.54M 10-Q · filed 2015-08-21 | ||
| 2013-12-31 | $2.84M 10-K · filed 2016-03-03 |